A Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF Among SSRI-Resistant Outpatients With Major Depressive Disorder (MDD)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Levomefolic acid (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 22 May 2013 Data were presented at the 2013 American Psychiatric Association (APA) and Society of Biological Psychiatry (SOBP) annual meetings, according to a Pamlab media release.
- 08 Jun 2010 Biomarkers information updated